Choroideremia Clinical Trial
Official title:
A Retrospective Cohort Analysis of the Natural Disease Progression of Patients With Choroideremia in Real-World Clinical Practice
The primary objective of this study is to quantify disease progression measured by best corrected visual acuity (BCVA) in the real-world setting among Choroideremia (CHM) participants. The secondary objectives are to describe demographic and baseline clinical characteristics among CHM participants and to match CHM participants in the Intelligent Research in Sight (IRIS®) Registry to Biogen's investigator sponsored trial (IST) study population using propensity score matching.
This study is a retrospective cohort study of CHM eyes and participants which will include all eligible participants and eyes with the first documented diagnosis of CHM from July 1st, 2013 to December 31st, 2019 that meet the study criteria. This study will be conducted using data from American Academy of Ophthalmology's (AAO) IRIS® Registry which captures CHM participant's demographics, clinical characteristics and clinical outcomes from 2013. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02553135 -
Choroideremia Gene Therapy Clinical Trial
|
Phase 2 | |
| Completed |
NCT01461213 -
Gene Therapy for Blindness Caused by Choroideremia
|
Phase 1/Phase 2 | |
| Completed |
NCT03507686 -
A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111
|
Phase 2 | |
| Recruiting |
NCT05258032 -
Structural and Functional Characterization of Rare Ocular Diseases
|
||
| Recruiting |
NCT05282953 -
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT05045703 -
The Dark-Adapted Retinal Function Response in Choroideremia (DARC) Study
|
N/A | |
| Recruiting |
NCT01866371 -
High Resolution Retinal Imaging
|
||
| Completed |
NCT01603576 -
Pilot Study of a Suprachoroidal Retinal Prosthesis
|
N/A | |
| Enrolling by invitation |
NCT03584165 -
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
|
Phase 3 | |
| Completed |
NCT03359551 -
Natural History of the Progression of Choroideremia Study
|
||
| Recruiting |
NCT02435940 -
Inherited Retinal Degenerative Disease Registry
|
||
| Active, not recruiting |
NCT04483440 -
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
|
Phase 1 | |
| Completed |
NCT02671539 -
THOR - Tübingen Choroideremia Gene Therapy Trial
|
Phase 2 | |
| Completed |
NCT02670980 -
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy
|
N/A | |
| Completed |
NCT02341807 -
Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations
|
Phase 1/Phase 2 | |
| Completed |
NCT03406416 -
Study of a Suprachoroidal Retinal Prosthesis
|
N/A | |
| Enrolling by invitation |
NCT05158049 -
Longitudinal Study of a Bionic Eye
|
||
| Terminated |
NCT02994368 -
"Natural History" Study of Choroideremia
|
||
| Terminated |
NCT01654562 -
The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00427180 -
IRIS PILOT - Extended Pilot Study With a Retinal Implant System
|
N/A |